Table 1.
Results of the motility analysis (CASA).
| Antioxidant | µM | TM (%) | PM (%) | VAP (µm/s) | VSL (µm/s) | VCL (µm/s) | LIN (%) | STR (%) | ALH (µm) | BCF (Hz) |
|---|---|---|---|---|---|---|---|---|---|---|
| Control | 41.0 ± 2.4c | 17.4 ± 0.6c | 60.0 ± 1.6c | 40.1 ± 0.2c | 107.0 ± 1.7b | 37.5 ± 0.5 | 67.2 ± 1.8 | 6.5 ± 0.18 | 19.6 ± 1.1b | |
| Rosiglitazone | 20 | 47.1 ± 1.6c | 15.7 ± 1.1c | 61.8 ± 1.7bc | 41.3 ± 0.4bc | 109.4 ± 1.4b | 37.8 ± 0.7 | 67.1 ± 1.4 | 6.2 ± 0.12 | 20.4 ± 1.5ab |
| 40 | 58.8 ± 1.7b | 25.3 ± 1.4b | 65.0 ± 0.6ab | 43.7 ± 0.9b | 111.4 ± 2.4ab | 39.5 ± 1.5 | 67.2 ± 1 | 6.2 ± 0.09 | 22.1 ± 1.5ab | |
| 60 | 68.4 ± 1.5a | 32.3 ± 1.2a | 67.2 ± 0.5a | 47.2 ± 1.3a | 117.3 ± 1.8a | 40.4 ± 1.4 | 70.3 ± 1.9 | 6.1 ± 0.16 | 25.6 ± 1.0a | |
| 80 | 43.7 ± 2.6c | 17.7 ± 1.5c | 60.8 ± 0.7bc | 41.0 ± 0.4bc | 108.2 ± 06b | 37.9 ± 0.3 | 67.6 ± 1.2 | 6.4 ± 0.06 | 19.7 ± 1.1b |
TM total motility, PM progressive motility, VSL curvilinear velocity, VAP average path velocity, VSL straight-line velocity, LIN linearity, STR straightness, ALH amplitude of lateral head displacement, BCF beat/cross frequency. Different superscripts within the same column indicate significant differences among groups (P < 0.05).